In conclusion, this study provides insight into the potential mechanisms underlying Si162 resistance in melanoma cells and identified 5 genes (CNTN6, ADD1, FGF18, C18orf25, and RPL13) as potential prognostic biomarkers for Si162 resistance. This evidence concerns the gene ADD1 and melanoma.